CHOP researcher leads trial of ALK inhibitor in neuroblastoma, lymphoma
A pill designed to zero in on abnormal genes that drive specific cancers has produced encouraging early results in children with an uncommon but aggressive type of lymphoma, as well as in children with a rare form of neuroblastoma.
Driving food, nutrition security to top of global agenda
In a guest post in the Chicago Council on Global Affairs' "Global Food for Thought" blog, Ertharin Cousin, executive director of the U.N. World Food Programme (WFP), examines global efforts to promote food security.
Abiraterone acetate can help eliminate prostate tumors
A hormone-depleting drug approved last year for the treatment of metastatic prostate cancer can help eliminate or nearly eliminate tumors in many patients with aggressive cancers that have yet to spread beyond the prostate, according to a clinical study to be presented at the annual meeting of the American Society ...
Contraception coverage rule ripples through college campuses
A fight over allowing HHS Secretary Kathleen Sebelius -- a key player in creating a mandate to force student health plans to cover contraception -- to speak at Georgetown's graduation continues. In the meantime, a Catholic university in Ohio is ending its student health insurance plan instead of complying with ...
Accretive seeks advice on collection standards from top health care policymakers
Accretive Health, subject of a recent report critical of its billing practices, will convene a panel of top policymakers on collection standards in the industry, it said Tuesday.
accretive, advice, care, collection, health, policymakers, seeks, standards, top
High-throughput sequencing can detect early signs of leukemia relapse
A study led by researchers at Fred Hutchinson Cancer Research Center has found that a next-generation, high-speed DNA-decoding technology called high-throughput sequencing can detect the earliest signs of potential relapse in nearly twice the number of leukemia patients as compared to flow cytometry, the current gold standard for detecting minimal ...
U.S. support for Global Fund may be ‘America’s greatest global health legacy’
"This year marks the 10th anniversary of the Global Fund to Fight AIDS, Tuberculosis and Malaria, the world's most powerful tool in the fight against the three pandemics," Jonathan Klein, co-founder and CEO of Getty Images, Inc., writes in this post in the Huffington Post Blog.